Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/HSA/APO-NAPROXEN TABLET 375 mg

Approved

THERAPEUTIC

APO-NAPROXEN TABLET 375 mg

APOTEX INC🇸🇬 Health Sciences Authority

Approval Date: Oct 26, 1995
Approval ID: e32476e88c59d7e1
Company: APOTEX INC
Type: Therapeutic

Approval Details

Approval Id: e32476e88c59d7e1
Drug Name: APO-NAPROXEN TABLET 375 mg
Product Name: APO-NAPROXEN TABLET 375 mg
Approval Number: SIN08425P
Approval Date: 1995-10-26
Registrant: PHARMAFORTE SINGAPORE PTE LTD
Licence Holder: PHARMAFORTE SINGAPORE PTE LTD
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: TABLET
Route Of Administration: ORAL
Atc Code: M01AE02
Atc Item Name: naproxen
Pharma Manufacturer Name: PHARMAFORTE SINGAPORE PTE LTD
Company Detail Path: /organization/pharmaforte-singapore-pte-ltd

Active Ingredients

NAPROXEN

375 mg

NAPROXEN

375 mg

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Oct 26, 1995

Approval ID

e32476e88c59d7e1

Type

Therapeutic

Back to HSA Approvals

APO-NAPROXEN TABLET 375 mg - HSA Drug Approval Details